Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Matrix Biol ; 83: 6-25, 2019 10.
Article in English | MEDLINE | ID: mdl-31220558

ABSTRACT

Osteoporosis is the most common degenerative bone disease that occurs when the balance of bone production and resorption is perturbed. Loss of bone mass or alteration in its quality leads to significant weakening of the bones and subsequently to higher fracture risk. Collagen XIII (ColXIII) is a conserved transmembrane protein expressed in many mesenchymal tissues. Here we show that ColXIII is a regulator of bone remodeling niche. In this study, we found that ColXIII expression is significantly upregulated in osteoporotic patients. In view of that, we studied bone homeostasis in ColXIII-overexpressing mice (Col13a1oe) up to 72 weeks of age and observed a cortical bone overgrowth followed by a drastic bone loss, together with increased bone vascularization. Moreover, our results demonstrate that the ColXIII-derived ectodomain enhances angiogenesis through ß1-integrins and the JNK pathway. Consequently, these data suggest that ColXIII has a role in age-dependent cortical bone deterioration with possible implications for osteoporosis and fracture risk.


Subject(s)
Collagen Type XIII/genetics , Collagen Type XIII/metabolism , Osteoblasts/cytology , Osteoporosis/metabolism , Up-Regulation , Animals , Cells, Cultured , Collagen Type XIII/chemistry , Disease Models, Animal , Humans , Integrin beta1/metabolism , MAP Kinase Signaling System , Mice , Mice, Transgenic , Osteoblasts/metabolism , Osteogenesis , Protein Domains
SELECTION OF CITATIONS
SEARCH DETAIL